MolecuLight
i:X™
provides real time imaging of bacteria in wound at the point-of-care.
MolecuLight
i:X™
for wound assessment
The
practitioner’s assessment of a wound is the first step in wound
care and its management. MolecuLight i:X
is a novel wound assessment device providing real time imaging of
bacteria in wound and periphery at the point of care 1.
Real
time imaging means prompt visualization and recognition of bacteria
in wounds and at the point-of-care. Stakeholders and practitioners
including surgeons, specialists in geriatrics, chiropodists and
podiatrists are empowered by immediate access to bacteriological
information in the palm of their hands; information that is both
accurate and at the patient bedside 1.
MolecuLight
i:X
is a ground breaking development in wound assessment techniques and
is making it possible for practitioners to make confident decision on
timely and suitable interventions that can impact patient lives early
in their wound health. MolecuLight i:X
can be used by practitioners in community-based hospitals and private
clinics.
The
Invisible is now visible
MolecuLight
i:X
is a novel wound assessment device which immediately identifies
moderate to high levels of bacteria in wounds and periphery, not
otherwise visible using industry standard wound assessment techniques
2. In
clinical practice today, wound infection diagnosis relies on visual
assessment of the wound under standard room lighting conditions. Yet
the human eye cannot visualize bacteria in wounds. MolecuLight i:X
uses fluorescence-guided imaging to identify bacteria in the wound,
including presence and location.
With
MolecuLight i:X,
practitioners are able to hold the digital image of a patient’s
wound in the palm of their hand and educate the patient at their
bedside on what they see and what they will do to improve the
patient’s current state of wound health.
(For
more information, contact us for a published case study on the
clinical use of MolecuLight i:X
and an asymptomatic diabetic foot ulcer 3.)
When
it comes to health care management,
MolecuLight i:X
is designed and developed with the practitioner and patient in mind
MolecuLight
i:X
is a novel imaging device that is designed for instantaneous
diagnosis by the practitioner to impact patient lives at the
point-of-care. This portable and hand-held device is safe, easy to
use and integrates well into clinical workflow. It shines blue violet
light to illuminate the wound area and records emitted light at
wavelengths specific to biological structures and pathogenic bacteria
in the wound and its periphery.
The
practitioner sees a composite image of the captured lights on a
liquid colored display (LCD) at the point-of-care to easily visualize
and precisely target clinically-important bacteria in and around the
wound. MolecuLight i:X
can be used to guide and improve microbiological sampling and
debridement of wounds in situ,
enabling diagnosis, treatment guidance and response assessment in
patients with chronic wounds.
The
clinical use of MolecuLight i:X
is published in a two part randomized clinical study on chronic
wounds 2.
Features
and benefits of MolecuLight i:X
for wound assessment and management is summarized below:
- A portable hand-held device
- Non-contact, non-invasive
- No use of contrast agents
- Safe and easy to use in a clinical setting
- Real time imaging of bacteria in wounds at the point-of-care diagnosis
- Surveillance of bacteria in wounds and response to treatment
- Integrates into current clinical workflow
- Early detection of bacteria in wounds of asymptomatic patients
For
more information on MolecuLight i:X
for your practice, please contact us by -
P:
647-362-4684
REFERENCES
1. DaCosta, R. S., Kulbatski, I.,
Lindvere-Teene, L., Starr, D., Blackmore, K., Silver, J. I., Linden,
R. (2015). Point-of-care autofluorescence imaging for real-time
sampling and treatment guidance of bioburden in chronic wounds:
first-in-human results. PloS One, 10(3), e0116623.
http://doi.org/10.1371/journal.pone.0116623
2. DaCosta, R. S. et al; unpublished data, Clinical Trials.Gov
NCT01378728, NCT01651845
3. Wu, Y. C., Smith, M., Chu, A., Lindvere-Teene, L., Starr, D.,
Tapang, K., … DaCosta, R. S. (2015). Handheld fluorescence imaging
device detects subclinical wound infection in an asymptomatic patient
with chronic diabetic foot ulcer: a case report. International
Wound Journal, n/a–n/a. http://doi.org/10.1111/iwj.12451
No comments:
Post a Comment